Pedroso de Lima M C, Chiche B H, Debs R J, Düzgüneş N
Cancer Research Institute, University of California, San Francisco 94143-0128.
Chem Phys Lipids. 1990 Mar;53(4):361-71. doi: 10.1016/0009-3084(90)90034-o.
Liposomes can be used as carriers of drugs in the treatment of viral, bacterial and protozoal infections. The potential for liposome-mediated therapy of Mycobacterium avium-intracellulare complex infections, one of the most common opportunistic infections in AIDS, is currently under study. Here, we have investigated the effect of the lipid-soluble antimycobacterial drugs ansamycin, clofazimine and CGP7040 on the thermotropic behavior of liposomes composed of dipalmitoylphosphatidylcholine (DPPC) or dipalmitoylphosphatidylglycerol (DPPG) using differential scanning calorimetry (DSC). In the presence of ansamycin (rifabutine), the peak gel-liquid crystalline phase transition temperature (Tm) of DPPG was reduced, as was the sub-transition temperature (Ts), whereas the Tm of DPPC was reduced only slightly. The temperature of the pre-transition (Tp) of DPPC was lowered, while the pre-transition of DPPG was abolished. Ansamycin also caused the broadening of the transition endotherm of both lipids. Equilibration of the drug/lipid complex for 1 or 5 days produced different thermotropic behavior. In the presence of clofazimine, the cooperativity of the phase transition of DPPG decreased. Above 10 mol% clofazimine formed two complexes with DPPG, as indicated by two distinguishable peaks in DSC thermograms. The Tm of both peaks were lowered as the mole fraction increased. Clofazimine had minimal interaction with DPPC. In contrast, CGP7040 interacted more effectively with DPPC than with DPPG, causing a reduction of the size of the cooperative unit of DPPC even at 2 mol%. The main transition of DPPC split into 3 peaks at 5 mol% drug. The pre-transition was abolished at all drug concentrations and the sub-transition disappeared at 10 mol% CGP7040. These studies suggest that maximal encapsulation of clofazimine in liposomes would require a highly negatively charged membrane, while that of CGP7040 would necessitate a zwitterionic membrane. We have also investigated the interaction of the water-soluble antibiotic pentamidine, which has been used against Pneumocystis carinii, the most lethal of AIDS-related opportunistic pathogens. Aerosol administration of this drug leads to long-term sequestration of the drug in the lungs. The DPPG/pentamidine complex exhibited a pre-transition at 3.5 degrees C, an endothermic peak at 42 degrees C, and an exothermic peak at 44.5 degrees C, followed by another endothermic peak at 55 degrees C. The exotherm depended on the history of the sample, requiring pre-incubation for several minutes below the 42 degrees C transition. These observations suggest that upon melting of the DPPG chains at 42 degrees C, the DPPG crystallizes as a DPPG/pentamidine complex that melts at 55 degrees C.
脂质体可作为药物载体用于治疗病毒、细菌和原生动物感染。鸟分枝杆菌复合群感染是艾滋病最常见的机会性感染之一,脂质体介导的该感染治疗潜力目前正在研究中。在此,我们使用差示扫描量热法(DSC)研究了脂溶性抗分枝杆菌药物安莎霉素、氯法齐明和CGP7040对由二棕榈酰磷脂酰胆碱(DPPC)或二棕榈酰磷脂甘油(DPPG)组成的脂质体热致行为的影响。在安莎霉素(利福布汀)存在下,DPPG的凝胶 - 液晶相转变峰值温度(Tm)降低,亚转变温度(Ts)也降低,而DPPC的Tm仅略有降低。DPPC的预转变温度(Tp)降低,而DPPG的预转变消失。安莎霉素还导致两种脂质的转变吸热峰变宽。药物/脂质复合物平衡1天或5天产生不同的热致行为。在氯法齐明存在下,DPPG相转变的协同性降低。高于10摩尔%的氯法齐明与DPPG形成两种复合物,如DSC热谱图中两个可区分的峰所示。随着摩尔分数增加,两个峰的Tm均降低。氯法齐明与DPPC的相互作用最小。相比之下,CGP7040与DPPC的相互作用比与DPPG更有效,即使在2摩尔%时也会导致DPPC协同单元尺寸减小。在5摩尔%药物时,DPPC的主要转变分裂为3个峰。在所有药物浓度下预转变消失,在10摩尔%CGP7040时亚转变消失。这些研究表明,氯法齐明在脂质体中的最大包封需要高度带负电荷的膜,而CGP7040则需要两性离子膜。我们还研究了水溶性抗生素喷他脒的相互作用,该药物已用于对抗卡氏肺孢子虫,这是与艾滋病相关的最致命的机会性病原体。雾化给药该药物会导致药物在肺部长期滞留。DPPG/喷他脒复合物在3.5℃出现预转变,在42℃出现吸热峰,在44.5℃出现放热峰,随后在55℃出现另一个吸热峰。放热峰取决于样品的历史,需要在42℃转变以下预孵育几分钟。这些观察结果表明,在42℃DPPG链熔化时,DPPG作为在55℃熔化的DPPG/喷他脒复合物结晶。